down arrow

Integer Holdings Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US45826H1095
USD
86.45
1.22 (1.43%)

Feb 06

NYS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

84.8686.88

52 Week

62.00144.76
Valuation
Technical
Day's Volume

CASH

172.86 k

Shareholding (Sep 2025)

FII

13.58%

Held by 125 FIIs

DII

24.47%

Held by 67 DIIs

Promoter

1.27%

How big is Integer Holdings Corp.?

22-Jun-2025

As of Jun 18, Integer Holdings Corp. has a market capitalization of $4.15 billion, with net sales of $1.76 billion and a net profit of $78.04 million over the last four quarters.

Market Cap: As of Jun 18, Integer Holdings Corp. has a market capitalization of 4,154.24 million, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Integer Holdings Corp. reported net sales of 1,755.28 million and a net profit of 78.04 million.<BR><BR>Balance Sheet Snapshot: As of Dec'24, the company reported shareholder's funds of 1,619.21 million and total assets of 3,077.97 million.

View full answer

What does Integer Holdings Corp. do?

22-Jun-2025

Integer Holdings Corporation is a medical device outsourcing manufacturer in the Pharmaceuticals & Biotechnology industry, with a market cap of approximately USD 4.15 billion. As of March 2025, it reported net sales of USD 436 million and a net profit of -USD 22 million.

Overview:<BR>Integer Holdings Corporation is a medical device outsource manufacturing company operating in the Pharmaceuticals & Biotechnology industry with a market cap of USD 4,154.24 Million.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 436 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -22 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 4,154.24 Million (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 45.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.75 <BR>Return on Equity: 5.83% <BR>Price to Book: 2.59 <BR><BR>Contact Details:<BR>Address: 5830 Granite Parkway., Suite 1150, PLANO TX : 75024 <BR>Tel: ['1 302 6587581', '1 716 7595809'] <BR>Fax: 1 302 6555049 <BR>Website: https://integer.net

View full answer

Who are in the management team of Integer Holdings Corp.?

22-Jun-2025

As of March 2022, the management team of Integer Holdings Corp. includes Bill Sanford (Independent Chairman), Joseph Dziedzic (CEO), and several independent directors: Pamela Bailey, James Hinrichs, Jean Hobby, Martin Maxwell, and Filippo Passerini. They oversee the company's strategic direction and operations.

As of March 2022, the management team of Integer Holdings Corp. includes the following individuals:<BR><BR>- Mr. Bill Sanford, Independent Chairman of the Board<BR>- Mr. Joseph Dziedzic, President, Chief Executive Officer, Director<BR>- Ms. Pamela Bailey, Independent Director<BR>- Mr. James Hinrichs, Independent Director<BR>- Ms. Jean Hobby, Independent Director<BR>- Mr. Martin Maxwell, Independent Director<BR>- Mr. Filippo Passerini, Independent Director<BR><BR>This team is responsible for guiding the company's strategic direction and overseeing its operations.

View full answer

Is Integer Holdings Corp. technically bullish or bearish?

28-Oct-2025

As of October 24, 2025, Integer Holdings Corp. is in a bearish trend, with negative indicators across multiple technical analyses, and has underperformed the S&P 500 significantly, showing a year-to-date return of -44.98%.

As of 24 October 2025, the technical trend for Integer Holdings Corp. has changed from mildly bearish to bearish. The weekly MACD is bearish, and the daily moving averages also indicate a bearish stance. The Bollinger Bands are bearish on both weekly and monthly time frames. Although the weekly RSI shows bullish momentum, it is not supported by other indicators, such as the KST and Dow Theory, which are bearish or show no trend. <BR><BR>In terms of performance, the stock has significantly underperformed compared to the S&P 500, with a year-to-date return of -44.98% versus the S&P 500's 15.47%. Overall, the current technical stance is bearish and indicates weakness in the stock's performance.

View full answer

Is Integer Holdings Corp. overvalued or undervalued?

11-Nov-2025

As of November 7, 2025, Integer Holdings Corp. is considered overvalued with a valuation grade of "expensive," reflected by a high P/E ratio of 45 and a year-to-date stock performance of -48.11%, significantly underperforming the S&P 500's 14.40% return.

As of 7 November 2025, the valuation grade for Integer Holdings Corp. has moved from very expensive to expensive, indicating a shift in perception regarding its valuation. The company appears to be overvalued based on its current metrics, particularly with a P/E ratio of 45, a Price to Book Value of 2.63, and an EV to EBITDA ratio of 15.31. In comparison, Sanmina Corp., a peer, has a more attractive P/E ratio of 39.80, suggesting that Integer Holdings Corp. is trading at a premium relative to its industry peers.<BR><BR>The company's recent stock performance has been notably poor, with a year-to-date return of -48.11%, significantly underperforming the S&P 500, which has returned 14.40% in the same period. This stark contrast further supports the conclusion that Integer Holdings Corp. is overvalued in the current market environment.

View full answer

Compare Integer Holdings Corp. with Similar Stocks

iRhythm Technologies, Inc.LivaNova PlcICU Medical, Inc.
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Poor long term growth as Operating profit has grown by an annual rate 8.76% of over the last 5 years

 
2

The company declared negative results in Mar'25 after positive results in Dec'24

3

With ROCE of 8.55%, it has a very expensive valuation with a 1.93 Enterprise value to Capital Employed

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 3,048 Million (Small Cap)

stock-summary
P/E

45.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.66

stock-summary
Return on Equity

5.16%

stock-summary
Price to Book

1.75

Revenue and Profits:
Net Sales:
467 Million
(Quarterly Results - Sep 2025)
Net Profit:
40 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
29.73%
0%
29.73%
6 Months
-17.95%
0%
-17.95%
1 Year
-38.65%
0%
-38.65%
2 Years
-17.96%
0%
-17.96%
3 Years
17.43%
0%
17.43%
4 Years
10.38%
0%
10.38%
5 Years
11.19%
0%
11.19%

Integer Holdings Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Is Integer Holdings Corp. overvalued or undervalued?

As of 7 November 2025, the valuation grade for Integer Holdings Corp. has moved from very expensive to expensive, indicating a shift in perception regarding its valuation. The company appears to be overvalued based on its current metrics, particularly with a P/E ratio of 45, a Price to Book Value of 2.63, and an EV to EBITDA ratio of 15.31. In comparison, Sanmina Corp., a peer, has a more attractive P/E ratio of 39.80, suggesting that Integer Holdings Corp. is trading at a premium relative to its industry peers. The company's recent stock performance has been notably poor, with a year-to-date return of -48.11%, significantly underperforming the S&P 500, which has returned 14.40% in the same period. This stark contrast further supports the conclusion that Integer Holdings Corp. is overvalued in the current market environment....

Read full news article

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
8.37%
EBIT Growth (5y)
8.76%
EBIT to Interest (avg)
3.68
Debt to EBITDA (avg)
3.75
Net Debt to Equity (avg)
0.75
Sales to Capital Employed (avg)
0.63
Tax Ratio
28.87%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
6.40%
ROE (avg)
5.72%

Valuation key factors

Factor
Value
P/E Ratio
45
Industry P/E
Price to Book Value
2.63
EV to EBIT
22.59
EV to EBITDA
15.31
EV to Capital Employed
1.93
EV to Sales
3.10
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
8.55%
ROE (Latest)
5.83%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 93 Schemes (60.6%)

Foreign Institutions

Held by 125 Foreign Institutions (13.58%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 8.39% vs 5.96% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 9.37% vs 32.97% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "466.60",
          "val2": "430.50",
          "chgp": "8.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "86.60",
          "val2": "91.70",
          "chgp": "-5.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "9.40",
          "val2": "14.60",
          "chgp": "-35.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.20",
          "val2": "-4.30",
          "chgp": "104.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "39.70",
          "val2": "36.30",
          "chgp": "9.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "114.90%",
          "val2": "146.30%",
          "chgp": "-3.14%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 10.62% vs 12.81% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 35.91% vs 36.45% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,719.80",
          "val2": "1,554.70",
          "chgp": "10.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "339.80",
          "val2": "255.90",
          "chgp": "32.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "56.40",
          "val2": "52.50",
          "chgp": "7.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-23.30",
          "val2": "-7.50",
          "chgp": "-210.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "121.10",
          "val2": "89.10",
          "chgp": "35.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "135.30%",
          "val2": "103.10%",
          "chgp": "3.22%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoYstock-summary

Sep'25
Sep'24
Change(%)
Net Sales
466.60
430.50
8.39%
Operating Profit (PBDIT) excl Other Income
86.60
91.70
-5.56%
Interest
9.40
14.60
-35.62%
Exceptional Items
0.20
-4.30
104.65%
Consolidate Net Profit
39.70
36.30
9.37%
Operating Profit Margin (Excl OI)
114.90%
146.30%
-3.14%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is 8.39% vs 5.96% in Sep 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 9.37% vs 32.97% in Sep 2024

All Quarterly Resultsstock-summary

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
1,719.80
1,554.70
10.62%
Operating Profit (PBDIT) excl Other Income
339.80
255.90
32.79%
Interest
56.40
52.50
7.43%
Exceptional Items
-23.30
-7.50
-210.67%
Consolidate Net Profit
121.10
89.10
35.91%
Operating Profit Margin (Excl OI)
135.30%
103.10%
3.22%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 10.62% vs 12.81% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 35.91% vs 36.45% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Integer Holdings Corp. stock-summary
stock-summary
Integer Holdings Corp.
Pharmaceuticals & Biotechnology
Integer Holdings Corporation, formerly Greatbatch, Inc., is a medical device outsource manufacturing company. The Company's segments include Medical and Non-Medical. Medical segment includes Portable Medical, Cardio & Vascular, and Cardiac & Neuromodulation product lines. Non-Medical segment includes Electrochem product line. It serves the cardiac, neuromodulation and vascular markets. It also serves the non-medical power solutions market. In addition, the Company develops batteries for niche applications in energy, military, and environmental markets. Its brands include Greatbatch Medical, Lake Region Medical and Electrochem. Its primary customers include multi-national original equipment manufacturers (OEMs) and their affiliated subsidiaries.
Company Coordinates stock-summary
Company Details
5830 Granite Parkway., Suite 1150 , PLANO TX : 75024
stock-summary
Tel: 1 302 65875811 716 7595809
stock-summary
https://integer.net
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."